Neuromodulation for Brain Tumors: Myth or Reality? A Narrative Review
暂无分享,去创建一个
A. Olivi | R. Pallini | A. Izzo | G. D. Della Pepa | G. Menna | N. Montano | Q. G. D’Alessandris | L. Lauretti | M. D'Ercole | Q. D’Alessandris
[1] Xing-jian Lin,et al. Deep brain stimulation improves central nervous system inflammation in Parkinson's disease: Evidence and perspectives , 2023, CNS neuroscience & therapeutics.
[2] F. Wagner,et al. Therapy Resistance of Glioblastoma in Relation to the Subventricular Zone: What Is the Role of Radiotherapy? , 2023, Cancers.
[3] G. Pavesi,et al. Efficacy and Tolerability of Perampanel in Brain Tumor-Related Epilepsy: A Systematic Review , 2023, Biomedicines.
[4] J. Suckling,et al. Transcriptomic and connectomic correlates of differential spatial patterning among gliomas , 2022, Brain : a journal of neurology.
[5] F. Winkler,et al. Insights and opportunities at the crossroads of cancer and neuroscience , 2022, Nature Cell Biology.
[6] S. Casas-Tintó,et al. Synaptic components are required for glioblastoma progression in Drosophila , 2022, PLoS genetics.
[7] S. May,et al. Genome-Wide Expression and Anti-Proliferative Effects of Electric Field Therapy on Pediatric and Adult Brain Tumors , 2022, International journal of molecular sciences.
[8] Shu-Hong Huang,et al. NLGN3 Upregulates Expression of ADAM10 to Promote the Cleavage of NLGN3 via Activating the LYN Pathway in Human Gliomas , 2021, Frontiers in Cell and Developmental Biology.
[9] Á. Pascual-Leone,et al. Personalised, image-guided, noninvasive brain stimulation in gliomas: Rationale, challenges and opportunities , 2021, EBioMedicine.
[10] F. Liu,et al. Neuronal-driven glioma growth requires Gαi1 and Gαi3 , 2021, Theranostics.
[11] Zaixu Cui,et al. Structural connectome quantifies tumour invasion and predicts survival in glioblastoma patients , 2021, bioRxiv.
[12] G. Reifenberger,et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. , 2021, Neuro-oncology.
[13] J. Huguenard,et al. NF1 mutation drives neuronal activity-dependent initiation of optic glioma , 2021, Nature.
[14] Dong Zhou,et al. Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma , 2020, Bioscience reports.
[15] W. Glac,et al. Subthalamic Deep Brain Stimulation Affects Plasma Corticosterone Concentration and Peripheral Immunity Changes in Rat Model of Parkinson’s Disease , 2020, Journal of Neuroimmune Pharmacology.
[16] H. Friedman,et al. Management of glioblastoma: State of the art and future directions. , 2020, CA: a cancer journal for clinicians.
[17] L. Ricci-Vitiani,et al. Rapid and Efficient Invasion Assay of Glioblastoma in Human Brain Organoids. , 2020, Cell reports.
[18] A. Yool,et al. Molecular Targets for Combined Therapeutic Strategies to Limit Glioblastoma Cell Migration and Invasion , 2020, Frontiers in Pharmacology.
[19] Hesheng Liu,et al. Resting-state fMRI Detects Alterations in Whole Brain Connectivity Related to Tumor Biology in Glioma Patients. , 2020, Neuro-oncology.
[20] H. Monyer,et al. Emerging intersections between neuroscience and glioma biology , 2019, Nature Neuroscience.
[21] Kexian Zhang,et al. Systemic screening identifies GABRD, a subunit gene of GABAA receptor as a prognostic marker in adult IDH wild-type diffuse low-grade glioma. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[22] Shawn M. Gillespie,et al. Electrical and synaptic integration of glioma into neural circuits , 2019, Nature.
[23] Pengfei Gao,et al. NLGN3 promotes neuroblastoma cell proliferation and growth through activating PI3K/AKT pathway. , 2019, European journal of pharmacology.
[24] A. Korshunov,et al. Acyl-CoA-Binding Protein Drives Glioblastoma Tumorigenesis by Sustaining Fatty Acid Oxidation. , 2019, Cell metabolism.
[25] Chen Wang,et al. Evaluation of serum extracellular vesicles as noninvasive diagnostic markers of glioma , 2019, Theranostics.
[26] A. Alessandrini,et al. Glutamate Receptors and Glioblastoma Multiforme: An Old “Route” for New Perspectives , 2019, International journal of molecular sciences.
[27] T. H. Nguyen,et al. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.
[28] Shi-ting Li,et al. CA10 and CA11 negatively regulate neuronal activity‐dependent growth of gliomas , 2019, Molecular oncology.
[29] R. Köhling,et al. AMPA receptor antagonist perampanel affects glioblastoma cell growth and glutamate release in vitro , 2019, PloS one.
[30] R. Nicoll,et al. Isoform-specific cleavage of neuroligin-3 reduces synapse strength , 2018, Molecular Psychiatry.
[31] A. Hillebrand,et al. Oscillatory brain activity associates with neuroligin-3 expression and predicts progression free survival in patients with diffuse glioma , 2018, Journal of Neuro-Oncology.
[32] Rui Liu,et al. Glioblastoma recurrence correlates with NLGN3 levels , 2018, Cancer medicine.
[33] S. Schmid,et al. Preclinical outcomes of Intratumoral Modulation Therapy for glioblastoma , 2018, Scientific Reports.
[34] F. Lieberman,et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial , 2017, JAMA.
[35] A. Olivi,et al. The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response , 2017, Neuro-oncology.
[36] T. Harkany,et al. Endogenous GABAA receptor activity suppresses glioma growth , 2017, Oncogene.
[37] J. Custódio,et al. Ionotropic glutamate receptor antagonists and cancer therapy: time to think out of the box? , 2017, Cancer Chemotherapy and Pharmacology.
[38] Parag Mallick,et al. Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion , 2015, Cell.
[39] L. Ricci-Vitiani,et al. Type-3 metabotropic glutamate receptors regulate chemoresistance in glioma stem cells, and their levels are inversely related to survival in patients with malignant gliomas , 2012, Cell Death and Differentiation.
[40] P. Gutin,et al. NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. , 2012, European journal of cancer.
[41] H. Monyer,et al. Diazepam binding inhibitor promotes progenitor proliferation in the postnatal SVZ by reducing GABA signaling. , 2012, Cell stem cell.
[42] J. Laterra,et al. Neuro-oncology: Unmasking the multiforme in glioblastoma , 2010, Nature Reviews Neurology.
[43] T. Mikkelsen,et al. Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] M. Passafaro,et al. The GluR2 subunit inhibits proliferation by inactivating Src‐MAPK signalling and induces apoptosis by means of caspase 3/6‐dependent activation in glioma cells , 2009, The European journal of neuroscience.
[45] L. Ricci-Vitiani,et al. Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme , 2008, Clinical Cancer Research.
[46] L. Ricci-Vitiani,et al. Type-3 metabotropic glutamate receptors negatively modulate bone morphogenetic protein receptor signaling and support the tumourigenic potential of glioma-initiating cells , 2008, Neuropharmacology.
[47] Mitchel S Berger,et al. Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.
[48] A. Bordey,et al. Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors , 2005, Nature Neuroscience.
[49] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[50] Ugo Orfanelli,et al. Isolation and Characterization of Tumorigenic, Stem-like Neural Precursors from Human Glioblastoma , 2004, Cancer Research.
[51] Y. Yoshida,et al. Blockage of Ca2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells , 2002, Nature Medicine.
[52] E. Holland,et al. Glioblastoma multiforme: the terminator. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] S. Weiss,et al. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.
[54] S. Schmid,et al. In Vitro Validation of Intratumoral Modulation Therapy for Glioblastoma. , 2016, Anticancer research.
[55] A. Álvarez-Buylla,et al. The heterogeneity of adult neural stem cells and the emerging complexity of their niche. , 2008, Cold Spring Harbor symposia on quantitative biology.